BioSpace News Archive

Business

Senti Bio Announces Third Quarter 2023 Results and Pipeline Updates

Senti Biosciences, Inc., a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, reported financial results for the third quarter of 2023.

November 13, 2023
·
12 min read
Business

POINT Biopharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights

POINT Biopharma Global Inc. today announced financial results for the third quarter ended September 30, 2023, and provided a business update.

November 13, 2023
·
12 min read
Head-to-head Trial of Prolonged-Release Oral Ketamine Formulation, KET01, and Intranasal SPRAVATO®, Finds Less Incidence of Dissociation or Cardiovascular Effects with Oral Treatment, at doses used for Treatment-Resistant Depression

Ketabon GmbH, a joint venture between HMNC Brain Health and Develco Pharma, announced favorable results from its head-to-head trial with KET01, the Company’s proprietary lead asset, versus SPRAVATO®, the FDA-approved intranasal spray for patients with Treatment-Resistant Depression.

November 13, 2023
·
7 min read
Business

Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results

Reneo Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2023 and provided a business update.

November 13, 2023
·
10 min read
Drug Development

aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023

aTyr Pharma, Inc. announced a poster presentation for its lead therapeutic candidate, efzofitimod, at the American College of Rheumatology Convergence 2023, which is being held November 10 – 15, 2023, in San Diego, CA.

November 13, 2023
·
5 min read
Business

Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update

Galectin Therapeutics, Inc., the leading developer of therapeutics that target galectin proteins, reported financial results and provided a business update for the three months ended September 30, 2023.

November 13, 2023
·
10 min read
Business

KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update

KALA BIO, Inc. today reported financial results for the third quarter ended September 30, 2023 and provided a corporate update.

November 13, 2023
·
14 min read
Business

IO Biotech Appoints Helen Collins, MD, to its Board of Directors

IO Biotech announced the appointment of Helen Collins, MD, to its board of directors.

November 13, 2023
·
4 min read
Business

Aerovate Therapeutics Announces Third Quarter Financial Results and Business Highlights

Aerovate Therapeutics, Inc. today announced financial results for the quarter ended September 30, 2023, and recent business highlights.

November 13, 2023
·
8 min read
Business

Comera Life Sciences Appoints Dorothy Clarke to Board of Directors

Comera Life Sciences Holdings, Inc. today announced it appointed Dorothy Clarke to its board of directors.

November 13, 2023
·
4 min read